Oxford Biodynamics

Oxford Biodynamics is a biotechnology company, which is engaged in biomarker research and development.

Oxford BioDynamics Plc (AIM: OBD) ('Oxford BioDynamics') is a biotechnology company focused on the discovery and development of epigenetic biomarkers for use within the pharmaceutical and biotechnology industry. The Company’s award-winning, proprietary technology platform, EpiSwitch, aims to accelerate the drug discovery and development process, improve the success rate of therap.